RWA Wealth Partners LLC Has $560,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

RWA Wealth Partners LLC boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,867 shares of the company’s stock after purchasing an additional 149 shares during the period. RWA Wealth Partners LLC’s holdings in HCA Healthcare were worth $560,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in HCA. Norges Bank acquired a new stake in HCA Healthcare during the 4th quarter valued at $840,286,000. Royal London Asset Management Ltd. increased its stake in shares of HCA Healthcare by 62.0% in the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock valued at $450,461,000 after buying an additional 574,239 shares in the last quarter. Principal Financial Group Inc. grew its holdings in HCA Healthcare by 120.1% during the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock worth $262,264,000 after acquiring an additional 476,756 shares during the last quarter. Meritage Group LP bought a new position in shares of HCA Healthcare in the third quarter worth about $150,548,000. Finally, Raymond James Financial Inc. bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $74,121,000. 62.73% of the stock is owned by institutional investors.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Up 0.1 %

HCA Healthcare stock opened at $345.86 on Wednesday. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company has a 50 day moving average of $325.79 and a 200-day moving average of $340.25. The stock has a market capitalization of $85.15 billion, a PE ratio of 15.74, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the business earned $5.90 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were given a $0.72 dividend. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is 13.11%.

Analysts Set New Price Targets

HCA has been the subject of several research reports. Bank of America lowered their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. Morgan Stanley dropped their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. KeyCorp lowered their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.